| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucin-1 | 33 | 2020 | 531 | 2.040 |
Why?
|
| Nanoparticles | 10 | 2024 | 1964 | 0.690 |
Why?
|
| Carcinoma, Ehrlich Tumor | 4 | 2015 | 23 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-abl | 6 | 2008 | 145 | 0.400 |
Why?
|
| Oligopeptides | 6 | 2018 | 1192 | 0.360 |
Why?
|
| Apoptosis | 21 | 2024 | 9514 | 0.350 |
Why?
|
| Oncogene Proteins | 4 | 2018 | 710 | 0.300 |
Why?
|
| Cell Line, Tumor | 30 | 2024 | 17075 | 0.270 |
Why?
|
| Antineoplastic Agents | 12 | 2024 | 13648 | 0.260 |
Why?
|
| Coumarins | 2 | 2004 | 120 | 0.240 |
Why?
|
| Pyrans | 1 | 2024 | 47 | 0.230 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2013 | 497 | 0.220 |
Why?
|
| Doxorubicin | 4 | 2024 | 2230 | 0.220 |
Why?
|
| Nanocapsules | 2 | 2015 | 92 | 0.220 |
Why?
|
| Peptides | 8 | 2017 | 4331 | 0.220 |
Why?
|
| Neoplasms | 10 | 2024 | 22340 | 0.210 |
Why?
|
| Isocoumarins | 4 | 2006 | 21 | 0.190 |
Why?
|
| Cell Survival | 10 | 2018 | 5747 | 0.180 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2003 | 147 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2021 | 1410 | 0.180 |
Why?
|
| Drug Synergism | 7 | 2024 | 1749 | 0.180 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2020 | 43 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2000 | 56 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2022 | 2453 | 0.170 |
Why?
|
| Transcription Factor RelA | 3 | 2016 | 252 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2022 | 2878 | 0.160 |
Why?
|
| Drug Delivery Systems | 7 | 2024 | 2207 | 0.160 |
Why?
|
| Caspases | 5 | 2011 | 880 | 0.160 |
Why?
|
| DNA Damage | 4 | 2006 | 2457 | 0.160 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2022 | 777 | 0.150 |
Why?
|
| Oleanolic Acid | 2 | 2010 | 43 | 0.150 |
Why?
|
| Quinazolinones | 1 | 2020 | 219 | 0.150 |
Why?
|
| Paclitaxel | 4 | 2018 | 1728 | 0.150 |
Why?
|
| Polymers | 3 | 2022 | 1621 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 6220 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 616 | 0.140 |
Why?
|
| Multiple Myeloma | 5 | 2024 | 5197 | 0.140 |
Why?
|
| Polyesters | 3 | 2024 | 372 | 0.140 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 483 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 8 | 2020 | 3750 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2016 | 3646 | 0.140 |
Why?
|
| Reactive Oxygen Species | 8 | 2017 | 2140 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 101 | 0.140 |
Why?
|
| Mice, Nude | 9 | 2018 | 3618 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2024 | 1352 | 0.130 |
Why?
|
| Maleates | 1 | 2015 | 18 | 0.130 |
Why?
|
| Mice | 26 | 2024 | 81819 | 0.130 |
Why?
|
| I-kappa B Kinase | 2 | 2007 | 248 | 0.130 |
Why?
|
| Nitrophenols | 1 | 2016 | 169 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2005 | 2056 | 0.130 |
Why?
|
| Polystyrenes | 1 | 2015 | 102 | 0.120 |
Why?
|
| Drug Design | 1 | 2020 | 1042 | 0.120 |
Why?
|
| Enzyme Activation | 9 | 2013 | 3586 | 0.120 |
Why?
|
| Cell Proliferation | 9 | 2020 | 10429 | 0.110 |
Why?
|
| Amino Acid Sequence | 12 | 2015 | 13400 | 0.110 |
Why?
|
| Cell Nucleus | 7 | 2011 | 2867 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2018 | 3608 | 0.110 |
Why?
|
| Animals | 31 | 2024 | 168764 | 0.100 |
Why?
|
| Ferric Compounds | 1 | 2014 | 368 | 0.100 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 657 | 0.100 |
Why?
|
| Tissue Distribution | 3 | 2023 | 2266 | 0.100 |
Why?
|
| Poloxamer | 2 | 2022 | 56 | 0.100 |
Why?
|
| Transcriptional Activation | 3 | 2009 | 1744 | 0.100 |
Why?
|
| Cytotoxins | 1 | 2012 | 154 | 0.100 |
Why?
|
| Protein Binding | 11 | 2015 | 9296 | 0.100 |
Why?
|
| Drug Carriers | 3 | 2024 | 700 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2002 | 2631 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2017 | 4348 | 0.090 |
Why?
|
| U937 Cells | 4 | 2009 | 259 | 0.090 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 1019 | 0.090 |
Why?
|
| Oxidative Stress | 4 | 2016 | 3141 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 314 | 0.090 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 108 | 0.090 |
Why?
|
| I-kappa B Proteins | 2 | 2009 | 209 | 0.090 |
Why?
|
| Magnetite Nanoparticles | 1 | 2012 | 309 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2016 | 1075 | 0.090 |
Why?
|
| Immunoconjugates | 1 | 2018 | 981 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2003 | 440 | 0.080 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 17594 | 0.080 |
Why?
|
| Antigens, Neoplasm | 4 | 2006 | 2002 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 2020 | 6942 | 0.080 |
Why?
|
| Disulfides | 1 | 2011 | 462 | 0.080 |
Why?
|
| Protein Multimerization | 4 | 2017 | 959 | 0.080 |
Why?
|
| Staurosporine | 1 | 2010 | 240 | 0.080 |
Why?
|
| Oxidation-Reduction | 5 | 2017 | 2218 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 2880 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2015 | 461 | 0.080 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2008 | 43 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 634 | 0.080 |
Why?
|
| Receptors, Death Domain | 1 | 2008 | 31 | 0.080 |
Why?
|
| Phosphorylation | 10 | 2011 | 8278 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 360 | 0.080 |
Why?
|
| Cell Cycle | 3 | 2011 | 2920 | 0.080 |
Why?
|
| Hep G2 Cells | 3 | 2014 | 379 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2010 | 430 | 0.080 |
Why?
|
| Caspase 8 | 1 | 2008 | 198 | 0.070 |
Why?
|
| Immunoblotting | 5 | 2011 | 1644 | 0.070 |
Why?
|
| HCT116 Cells | 4 | 2011 | 399 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 1682 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2017 | 3404 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 5337 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 7 | 2013 | 6113 | 0.070 |
Why?
|
| Breast Neoplasms | 6 | 2018 | 21056 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 870 | 0.070 |
Why?
|
| Mitochondria | 6 | 2009 | 3673 | 0.070 |
Why?
|
| Antimitotic Agents | 1 | 2006 | 28 | 0.070 |
Why?
|
| RNA, Small Interfering | 6 | 2016 | 3421 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 1240 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1984 | 0.070 |
Why?
|
| Humans | 56 | 2024 | 765968 | 0.070 |
Why?
|
| Cytoplasm | 5 | 2011 | 1500 | 0.060 |
Why?
|
| Cysteine | 2 | 2011 | 898 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 3 | 2015 | 2822 | 0.060 |
Why?
|
| Neuregulin-1 | 2 | 2004 | 140 | 0.060 |
Why?
|
| Galectin 3 | 1 | 2007 | 238 | 0.060 |
Why?
|
| beta Catenin | 3 | 2005 | 1043 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 1088 | 0.060 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4260 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 689 | 0.060 |
Why?
|
| Mucins | 2 | 2006 | 567 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 2942 | 0.060 |
Why?
|
| Folic Acid | 1 | 2012 | 1338 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 8611 | 0.060 |
Why?
|
| Amino Acid Motifs | 3 | 2015 | 924 | 0.060 |
Why?
|
| Protein Subunits | 4 | 2011 | 939 | 0.060 |
Why?
|
| Androgens | 1 | 2012 | 1279 | 0.060 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2004 | 108 | 0.060 |
Why?
|
| Signal Transduction | 8 | 2017 | 23601 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3946 | 0.050 |
Why?
|
| Drug Stability | 2 | 2015 | 288 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 414 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 1325 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 283 | 0.050 |
Why?
|
| Leukemia | 1 | 2011 | 1522 | 0.050 |
Why?
|
| Caspase 3 | 4 | 2010 | 731 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2017 | 1151 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 618 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2003 | 155 | 0.050 |
Why?
|
| Epirubicin | 1 | 2022 | 82 | 0.050 |
Why?
|
| Cell Death | 3 | 2015 | 1679 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2014 | 720 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2017 | 2086 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3672 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2010 | 2485 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2844 | 0.050 |
Why?
|
| Taxoids | 1 | 2005 | 665 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 187 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2012 | 11083 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2002 | 124 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9249 | 0.050 |
Why?
|
| Carcinoma | 2 | 2018 | 2312 | 0.050 |
Why?
|
| Autophagy | 1 | 2009 | 1351 | 0.050 |
Why?
|
| Mitosis | 1 | 2006 | 1173 | 0.050 |
Why?
|
| Camptothecin | 1 | 2004 | 600 | 0.040 |
Why?
|
| Mitochondrial Proteins | 2 | 2004 | 975 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 376 | 0.040 |
Why?
|
| Necrosis | 3 | 2011 | 1617 | 0.040 |
Why?
|
| Luciferases | 3 | 2011 | 713 | 0.040 |
Why?
|
| Cytarabine | 1 | 2002 | 698 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2002 | 538 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2002 | 4427 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 5389 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9601 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2000 | 249 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 5786 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 381 | 0.040 |
Why?
|
| Contrast Media | 1 | 2012 | 5329 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 870 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4562 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 679 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2017 | 12131 | 0.040 |
Why?
|
| Rats | 4 | 2020 | 23707 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2015 | 1885 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2002 | 647 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2012 | 2927 | 0.040 |
Why?
|
| Antigens | 1 | 2004 | 1438 | 0.040 |
Why?
|
| Cisplatin | 2 | 2004 | 1658 | 0.040 |
Why?
|
| Oncogenes | 1 | 2003 | 1235 | 0.040 |
Why?
|
| Autoantigens | 1 | 2002 | 883 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1889 | 0.040 |
Why?
|
| Protein Transport | 2 | 2015 | 1939 | 0.040 |
Why?
|
| Glucose | 1 | 2009 | 4335 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1745 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2004 | 1963 | 0.030 |
Why?
|
| HeLa Cells | 3 | 2009 | 3067 | 0.030 |
Why?
|
| Up-Regulation | 4 | 2007 | 4137 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2002 | 1648 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2011 | 5020 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 4520 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2016 | 1061 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2195 | 0.030 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2016 | 103 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2228 | 0.030 |
Why?
|
| Erythrocyte Aggregation | 1 | 2015 | 35 | 0.030 |
Why?
|
| Cell Line | 5 | 2011 | 15543 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4913 | 0.030 |
Why?
|
| Gene Silencing | 2 | 2016 | 1505 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 292 | 0.030 |
Why?
|
| MicroRNAs | 2 | 2012 | 3785 | 0.030 |
Why?
|
| Albumins | 1 | 2018 | 577 | 0.030 |
Why?
|
| bcl-X Protein | 2 | 2009 | 414 | 0.030 |
Why?
|
| Luminescent Proteins | 2 | 2011 | 839 | 0.030 |
Why?
|
| Transfection | 3 | 2011 | 5743 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2017 | 416 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1333 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2015 | 405 | 0.030 |
Why?
|
| src Homology Domains | 2 | 2006 | 361 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 610 | 0.030 |
Why?
|
| Caspase 9 | 2 | 2005 | 184 | 0.030 |
Why?
|
| Azacitidine | 1 | 2016 | 334 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.030 |
Why?
|
| Piperazines | 3 | 2016 | 2549 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 588 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 577 | 0.030 |
Why?
|
| Female | 13 | 2024 | 396112 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 7599 | 0.030 |
Why?
|
| Aorta | 1 | 2002 | 2028 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 656 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 2014 | 91 | 0.030 |
Why?
|
| Binding Sites | 3 | 2011 | 6001 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2015 | 235 | 0.030 |
Why?
|
| Cytochromes c | 2 | 2004 | 173 | 0.030 |
Why?
|
| Pyrimidines | 2 | 2005 | 3047 | 0.030 |
Why?
|
| Hemolysis | 1 | 2015 | 406 | 0.030 |
Why?
|
| Lactates | 1 | 2014 | 398 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2012 | 12768 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2015 | 898 | 0.030 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 2012 | 23 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 1242 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 6309 | 0.030 |
Why?
|
| Reducing Agents | 1 | 2011 | 12 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2003 | 431 | 0.020 |
Why?
|
| Cadherins | 1 | 2016 | 900 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2004 | 18973 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1638 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1966 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 951 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2012 | 696 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 390 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 2477 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2011 | 184 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 8102 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 684 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 446 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 967 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
| Dimerization | 1 | 2011 | 880 | 0.020 |
Why?
|
| Cell Movement | 1 | 2002 | 5194 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1631 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2011 | 262 | 0.020 |
Why?
|
| Myelopoiesis | 1 | 2010 | 135 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 2003 | 1083 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7851 | 0.020 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2009 | 84 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3737 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 649 | 0.020 |
Why?
|
| Biopolymers | 1 | 2009 | 181 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 1188 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2531 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5379 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5783 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 56 | 0.020 |
Why?
|
| Benzamides | 2 | 2005 | 1377 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13451 | 0.020 |
Why?
|
| Asparagine | 1 | 2007 | 120 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11888 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 857 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11868 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 752 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2003 | 3089 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 256 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2006 | 81 | 0.020 |
Why?
|
| Mutation | 5 | 2011 | 30198 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2007 | 146 | 0.020 |
Why?
|
| Mucin-4 | 1 | 2006 | 33 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 252 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 9373 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 595 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 528 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4025 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 805 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 743 | 0.020 |
Why?
|
| RNA Stability | 1 | 2007 | 319 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 221 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6499 | 0.010 |
Why?
|
| Body Weight | 1 | 2015 | 4622 | 0.010 |
Why?
|
| CHO Cells | 1 | 2007 | 1372 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2006 | 5881 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 1107 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 2900 | 0.010 |
Why?
|
| Glycosylation | 1 | 2007 | 1100 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 3715 | 0.010 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2004 | 70 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3559 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1957 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 1066 | 0.010 |
Why?
|
| Trans-Activators | 2 | 2003 | 2850 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2411 | 0.010 |
Why?
|
| Carcinogenicity Tests | 1 | 2003 | 39 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3602 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 116 | 0.010 |
Why?
|
| gamma Catenin | 1 | 2003 | 45 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2012 | 2475 | 0.010 |
Why?
|
| Desmoplakins | 1 | 2003 | 65 | 0.010 |
Why?
|
| Adenine | 1 | 2009 | 994 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2003 | 92 | 0.010 |
Why?
|
| DNA | 1 | 2017 | 7202 | 0.010 |
Why?
|
| Anthracenes | 1 | 2003 | 82 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2003 | 123 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2004 | 4159 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2011 | 11641 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 1999 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 195 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10729 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 71 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2832 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 53 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4424 | 0.010 |
Why?
|
| Tyrosine | 1 | 2006 | 1428 | 0.010 |
Why?
|
| Male | 6 | 2017 | 363698 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7421 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 812 | 0.010 |
Why?
|
| RNA Caps | 1 | 2002 | 72 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2394 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2002 | 83 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2002 | 121 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 449 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2003 | 473 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2002 | 182 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2002 | 111 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3222 | 0.010 |
Why?
|
| Microtubules | 1 | 2006 | 1062 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 562 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 698 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 564 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 856 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 1672 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 1229 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 885 | 0.010 |
Why?
|
| Homeostasis | 1 | 2011 | 3336 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1524 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1984 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2003 | 722 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 824 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4475 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2004 | 1591 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4165 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 2832 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2002 | 839 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 1417 | 0.010 |
Why?
|
| Models, Biological | 2 | 2004 | 9443 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2060 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2274 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18293 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3681 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12403 | 0.010 |
Why?
|
| Inflammation | 1 | 2017 | 10850 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6493 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2008 | 1927 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 3801 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 1529 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 4772 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4241 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 1611 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3634 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3690 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16721 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2002 | 2446 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2002 | 2056 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2003 | 2593 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2423 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 13632 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3596 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 3430 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5125 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2002 | 5696 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 59489 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 40065 | 0.000 |
Why?
|
| Aged | 1 | 2010 | 171117 | 0.000 |
Why?
|